Dynamic aspects of antibody:oligosaccharide complexes characterized by molecular dynamics simulations and saturation transfer difference nuclear magnetic resonance-Reference-Cited by-同舟云学术

Dynamic aspects of antibody:oligosaccharide complexes characterized by molecular dynamics simulations and saturation transfer difference nuclear magnetic resonance

Published:2011-05-24 Issue:12 Volume:21 Page:1570-1579
ISSN:1460-2423
Container-title:Glycobiology
language:en
Short-container-title:

Author:

Theillet François-Xavier,Frank Martin,Vulliez-Le Normand Brigitte,Simenel Catherine,Hoos Sylviane,Chaffotte Alain,Bélot Frédéric,Guerreiro Catherine,Nato Farida,Phalipon Armelle,Mulard Laurence A,Delepierre Muriel

Publisher

Oxford University Press (OUP)

Subject

Biochemistry

Link

http://academic.oup.com/glycob/article-pdf/21/12/1570/16654635/cwr059.pdf

Reference72 articles.

1. Molecular docking of carbohydrate ligands to antibodies: Structural validation against crystal structures;Agostino;J Chem Inf Model,2009

2. Identification of preferred carbohydrate binding modes in xenoreactive antibodies by combining conformational filters and binding site maps;Agostino;Glycobiology,2010

3. NMR analysis of carbohydrate-protein interactions;Angulo;Methods Enzymol,2006

4. Carbohydrate vaccines: Developing sweet solutions to sticky situations?;Astronomo;Nat Rev Drug Discov,2010

5. The structure of siglec-7 in complex with sialosides: Leads for rational structure-based inhibitor design;Attrill;Biochem J,2006

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Shigella flexneri 2a synthetic glycan-based vaccine induces a long-lasting immune response in adults;npj Vaccines;2023-03-10

2. Semisynthetic Glycoconjugate Vaccine Candidates against Escherichia coli O25B Induce Functional IgG Antibodies in Mice;JACS Au;2022-08-31

3. The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella;ACS Central Science;2022-03-17

4. Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study;The Lancet Infectious Diseases;2021-04

5. Exploratory N‐Protecting Group Manipulation for the Total Synthesis of Zwitterionic Shigella sonnei Oligosaccharides;Chemistry – A European Journal;2021-03